Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Life Sciences to Create New US Headquarters

Published: Wednesday, August 20, 2014
Last Updated: Thursday, August 21, 2014
Bookmark and Share
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.

GE Healthcare Life Sciences announced today that it will open a new 160,000 square-foot facility in Marlborough, Massachusetts, as the new headquarters for its US operations. A $21M investment in the long-term future of this key GE Healthcare growth business, it will establish a new site for more than 500 GE Healthcare Life Sciences employees, including the creation of more than 220 new jobs in the US's leading life sciences and biotechnology cluster. Recruitment has begun with the site scheduled to open in Spring 2015, offering a dynamic working environment and career opportunities with a global leader in technology, science and business innovation.

“Our new facility in Massachusetts will position us for continued innovation and competition in such a fast-paced, innovative industry,” said Kieran Murphy, President and CEO of GE Healthcare Life Sciences. “We will be close to industry-leading talent, customers, and world-class academic and medical institutions across all the industry sectors we serve, from biotech and pharma, to diagnostics and medical devices.”

“Today, Massachusetts’ life sciences sectors are the fastest-growing sectors of our economy. We look forward to welcoming the U.S. life sciences headquarters of GE Healthcare and are pleased that the company will create a substantial number of new, STEM-related job opportunities in central Massachusetts,” said Governor Deval Patrick.

This investment will transform a currently unoccupied space into state-of-the-art labs, customer application facilities, and office space to complement GE Healthcare Life Sciences’ existing manufacturing capability in Westborough, Mass. The facility will consolidate GE Healthcare Life Sciences’ US East Coast presence, bringing together a critical mass of talent and expertise-dedicated collaboration, innovation and leadership in the industry. When fully operational, the new facility will bring more than 220 highly qualified new job opportunities to the area, including highly skilled positions such as lab technicians, biologists, medical doctors, process engineers, and customer service representatives.

GE Healthcare Life Sciences’ $4B business has more than 11,500 employees in over 100 countries, with the mission of enabling a new era of molecular and precision medicine. By providing customers with tools, insight and knowledge, GE Healthcare helps them accelerate the journey from biological understanding to clinical therapy. The new US headquarters will house employees from across the Life Sciences business, including its research, bioprocessing, medical imaging, in vitro diagnostics and services segments.

“Marlborough continues to be a center for innovation. This GE Healthcare Life Sciences investment, adding more than 220 new jobs with an exciting biotechnology leader, is proof that innovation is thriving outside Route 128, and of Marlborough’s ability to build the necessary infrastructure to attract top-tier, global life sciences companies,” said Mayor Arthur Vigeant.

“MassBIO continues to be engaged in policy, economic development and STEM education to foster the world’s leading biotech cluster. We are excited to continue work with industry leaders like GE Healthcare Life Sciences to promote innovation in the Greater Marlborough area,” said Robert Coughlin, President, MassBIO.

GE Healthcare Life Sciences has been actively supporting the development of new therapies for more than 60 years, with innovative technologies, services and solutions that enable the research, development, manufacture and use of the next generation of therapies. With technologies along the entire drug development, production and clinical continuum, GE helps scientists and physicians answer critical questions at every stage, from early research to patient diagnosis in the clinic.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Diagnosing Bacterial Infections in Blood Samples
Researchers have diagnosed a bacterial infection from a blood sample in infants.
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Misdiagnosis in HCM Tests
Genetic tests for potentially fatal heart anomaly can misdiagnose condition in black Americans.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Examining New Hypotheses for Undiagnosed Patients
UnDx Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses.
Automating Genetic Analysis
Researchers are looking to have computers help perform genetic analysis when scientists study a patient's genome to diagnose a disease.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!